반응식
F[C:2](F)(F)C(O)=O.[NH2:8][C:9]1[C:14]([C:15]([C:17]2[CH:22]=[C:21]([F:23])[CH:20]=[CH:19][C:18]=2[O:24][CH3:25])=[O:16])=[CH:13]N=[C:11]([NH:26][CH:27]2[CH2:32][CH2:31][NH:30][CH2:29][CH2:28]2)[N:10]=1.[CH3:33][O:34][C:35](Cl)=[O:36]>>[CH3:33][O:34][C:35]([N:30]1[CH2:31][CH2:32][CH:27]([NH:26][C:11]2[CH:2]=[CH:13][C:14]([C:15](=[O:16])[C:17]3[CH:22]=[C:21]([F:23])[CH:20]=[CH:19][C:18]=3[O:24][CH3:25])=[C:9]([NH2:8])[N:10]=2)[CH2:28][CH2:29]1)=[O:36]참가 물질
3
실험 절차
The title compound was prepared from [4-amino-2-(piperidin-4-ylamino)-pyrimidin-5-yl]-(5-fluoro-2-methoxy-phenyl)-methanone trifluoroacetic acid salt (Example 22) and methylchloroformate (Aldrich 99%) using the procedure described in Example 24. HRMS, observed: 403.1781, Calcd for (M+H)+: 403.1776.
출처 및 근거
- ORD 기록
- ord-31a61cf1ce0740a79d0ce110afcd2bff
- 출처 데이터셋
- uspto-grants-2008_09
- 특허 번호
- US07423051B2
연결된 노트
불러오는 중…